#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Amyotrophic lateral sclerosis Cold type haemolytic anaemia Keratosis follicular Diabetes insipidus Progressive supranuclear palsy Parkinson's disease Short stature Kearns-Sayre syndrome Hypophosphatasia Angiosarcoma recurrent SAPHO syndrome Carcinoid tumour Anaemia Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Short-bowel syndrome Rhabdomyosarcoma recurrent – Diagnostics Primary mediastinal large B-cell lymphoma – Treatment Rett syndrome Shprintzen-Goldberg syndrome – Trials in Disease VEXAS syndrome Rhabdomyosarcoma – Life with Disease MELAS syndrome – Trials in Disease Burkitt’s lymphoma – Diagnostics Angiosarcoma non-metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Acetate (1-13C) Calcium Polystyrene Sulfonate NORGESTIMATE Platelet Concentrate Etuvetidigene Autotemcel R-Azasetron Besilate Bepirovirsen Sunvozertinib Donidalorsen Niflumic Acid Napabucasin Xaluritamig Valsartan AMO959 Thiamazole Dexamethasone Isonicotinate Peppermint Oil Natalizumab Vixarelimab Insulin Aspart More therapies…

    Learn about Your Condition

    Thymoma malignant Leukocyte adhesion deficiency Pharyngeal cancer stage I Testicular germ cell tumour Mesothelioma malignant Benign renal neoplasm Chronic spontaneous urticaria Intermittent claudication Meningioma Peripheral ischaemia Follicular lymphoma stage II Behavioural addiction Ewing's sarcoma Acute respiratory failure Pancreatic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clintrial s.r.o.

Clintrial s.r.o.

Pocernicka 1427/16, Strasnice, Prague, 100 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of NBI-1065845 for Adults with Major Depressive Disorder

    Recruiting

    3 1
    Investigated Drugs:
    • 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
    Croatia Czechia Poland

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
    Bulgaria Czechia Germany Poland

  • Study on ITI-1284 for Treating Agitation in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    • Apremilast
    Belgium Bulgaria Croatia Czechia Estonia Germany +6

  • Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

    Recruiting

    3 1
    Investigated Drugs:
    • SELTOREXANT
    Bulgaria Czechia Italy Poland Portugal Romania +3

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland

  • Study on the Effects of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

    Recruiting

    2 1
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Czechia Hungary Poland Slovakia

  • Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer’s-Related Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Safety Study of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Tardive dyskinesia
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Czechia Poland

  • Long-Term Safety Study of ACP-204 for Adults with Alzheimer’s Disease Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain
Previous Page
1 2 3 4 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!